VIDEO: Access to treatment and vaccines to COVID-19 – what should we do about patents?
The COVID-19 pandemic has exposed the flaws of the current innovation system, which is one that does not promote cooperation for the advancement of science; but on the contrary, the competition between large multinationals and countries has led to a delay in the development of an effective vaccine and treatment. Although cooperation strategies have been proposed, they appear not to solve the middle-income countries’ problems of access, those that do not have access to philanthropy and whose resources are not enough to provide their populations with effective access to a vaccine or a patented treatment. At the same time, COVID-19 has shown the need to strengthen local production capacities so that countries can assure their sanitary sovereignty in the face of the hoarding of the first batches of products by rich countries.
What alternatives do low- and middle-income countries have to guarantee access to vaccines and treatments for their populations? The track’s keynote and panel will address the different proposals that have arisen to answer this question: (1) the UN Secretary-General’s proposal on considering all COVID-19-related innovations to be a global public good; (2) the Costa Rican President’s proposal, to the World Health Organization, on pooling rights to COVID-19-related technologies; (3) possibility of using the TRIPS flexibilities; and (4) a proposal on completely abolishing drug and vaccine patents due to the impact they have had on the health of the poorest countries’ population.
Participants:
Lorena Di Giano is Lawyer specialized in Human Rights, Access to Medicines and Intellectual Property. Executive Director of Grupo Efecto Positivo Foundation (GEP). General Coordinator of RedLAM (Latin American Network for Access to Medicines). Member of the Expert Advisory Group of the UN High Level Panel on Access to Medicines and Innovation.
Peter Maybarduk directs Public Citizen’s access to medicines and knowledge economy group, which helps partners worldwide secure the benefits of science and technology for all. The group’s work has shaped legislation and executive action to make medicine affordable and changed the course of trade negotiations to protect health and digital rights. Today, Maybarduk and his colleagues are working to improve COVID-19 pandemic response and prevent a global vaccine apartheid.
Dr. Albin Chaves Matamoros is a Surgeon from the University of Costa Rica. Specialist in Internal Medicine from the same University. Specialist in Clinical Pharmacology, with studies at the Mario Negri Pharmacological Research Institute in Milano, Italy. Master in Pharmacoepidemiology from the Autonomous University of Barcelona. Resident of the Drug Information Division of the United States Pharmacopeia.
He has published more than 25 articles on Pharmacoepidemiology in different national and international journals and has participated in more than 75 Medical Congresses in Latin America, Europe and the United States.
He is currently the Director of the Pharmacoepidemiology Directorate and Coordinator of the Central Committee of Pharmacotherapy of the Costa Rican Social Security Fund (CCSS).
Moderator: Ángela Acosta Santamaría, Health Mission.
Date
- 08 Oct 2020
- Expired!
Time
- 3:00 pm - 4:45 pm
Local Time
- Timezone: America/New_York
- Date: 08 Oct 2020
- Time: 11:00 am - 12:45 pm
More Info
Other Organizers
Speakers
-
Lorena Di Giano
-
Peter Maybarduk
-
Albin Chaves Matamoros
-
Ángela Acosta Santamaría
